AnGes Inc
AJW
Company Profile
Business description
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.
Contact
7-7-15, Saito-asagi
4F, Saito Bio-Incubator
Ibaraki
Osaka567-0085
JPNSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
71
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,772.00 | 1.00 | -0.01% |
CAC 40 | 7,618.06 | 47.85 | -0.62% |
DAX 40 | 23,700.34 | 209.27 | -0.88% |
Dow JONES (US) | 44,094.77 | 275.50 | 0.63% |
FTSE 100 | 8,728.75 | 32.21 | -0.37% |
HKSE | 24,072.28 | 211.87 | -0.87% |
NASDAQ | 20,369.73 | 96.27 | 0.47% |
Nikkei 225 | 39,986.33 | 501.06 | -1.24% |
NZX 50 Index | 12,734.53 | 131.71 | 1.05% |
S&P 500 | 6,204.95 | 0.00 | 0.00% |
S&P/ASX 200 | 8,541.10 | 1.20 | -0.01% |
SSE Composite Index | 3,444.43 | 20.20 | 0.59% |